I want to make one thing pretty clear. I’ve just about had it with this
whole steroid controversy, what with it’s secret lists and tainted
records and bloody syringes. I’m having a hard time even caring about
it, because as Craig pointed out below, absolutely nothing surprises us
anymore. We’ve become desensitized to it all.
As baseball fans, we’ve forced ourselves to look the other way just
to move on and enjoy the game we love. Take a look at Mannywood, for
example. Baseball in the late-90s and early 2000s are like a troubled
uncle. Yeah, the dude was pretty messed up for a while, but he keeps
saying he has cleaned himself up. Let’s just give him the benefit of
the doubt, okay? He’ll turn himself around. Really, he will.
That said, it’s quite different when news like this concerns the
team you root for. Even though I’m not a Red Sox fan, seeing David
Ortiz hit that home run against Paul Quantrill in Game Four of the 2004
ALCS was one of my favorite memories as a baseball fan. It was
positively thrilling. But I can’t help but look at Ortiz differently
now. I’ve grown quite tired of reconsidering all the moments I have
I’m mad at these players, but cognizant that performance enhancing
drugs aren’t so cut and dry. Thus, it’s not so easy to just pass
judgement on them. Even Bob Gibson has said that he might have
considered using PEDs if they had been around during his time. We have
to accept that we are watching and rooting for some very competitive
individuals. Not just against the other team, but in even keeping a
roster spot. This do-whatever-it-takes attitude is what made David
Ortiz from a mere nice player in Minnesota to a prolific slugger in
Boston. As long as there are advantages to be had, players will seek
them out. Period.
A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.
Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.
For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.
The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.
Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.
Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.